APA (7th ed.) Citation

Neben, K., Jauch, A., Bertsch, U., Raab, M., Ho, A. D., Hose, D., & Goldschmidt, H. (2012). Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p. Blood, 119(4), .

Chicago Style (17th ed.) Citation

Neben, Kai, Anna Jauch, Uta Bertsch, Marc-Steffen Raab, Anthony Dick Ho, Dirk Hose, and Hartmut Goldschmidt. "Administration of Bortezomib Before and After Autologous Stem Cell Transplantation Improves Outcome in Multiple Myeloma Patients with Deletion 17p." Blood 119, no. 4 (2012).

MLA (9th ed.) Citation

Neben, Kai, et al. "Administration of Bortezomib Before and After Autologous Stem Cell Transplantation Improves Outcome in Multiple Myeloma Patients with Deletion 17p." Blood, vol. 119, no. 4, 2012.